Mucormycosis at the Time of COVID-19 Pandemic: A Review
DOI:
https://doi.org/10.3329/bjid.v9i9.62615Keywords:
Mucormycosis; COVID-19; Fungal co-infection; PandemicAbstract
Mucormycosis, an opportunistic fungal illness, has become a global health problem in the aftermath of the COVID-19 pandemic. This is mostly owing to a dramatic spike in COVID-19 infection in recent months in India, which was exacerbated by this fungal co-infection. Mucormycosis has an exceptionally high probability of death and lasting damage to the affected area. Although early action can save lives and mitigate the fungus's impact, it is frequently hard for the already overwhelmed health system in India due to the pandemic. Other variables, such as diabetes, have had a significant impact on the disease's outcome.
Bangladesh Journal of Infectious Diseases, April 2022;9(Suppl_1): S55-S57
Downloads
24
42
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mohammod Kamrul Islam, Tahaani Al Hoque Chowdhury
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright
Copyright on any research article in the Bangladesh Journal of Infectious Diseases is retained by the author(s).
The authors grant the Bangladesh Infection Research Association a license to publish the article and identify itself as the original publisher.
Articles in the Bangladesh Journal of Infectious Diseases are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)
This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.